| Literature DB >> 23846901 |
Benjamin Chaigne-Delalande1, Feng-Yen Li, Geraldine M O'Connor, Marshall J Lukacs, Ping Jiang, Lixin Zheng, Amber Shatzer, Matthew Biancalana, Stefania Pittaluga, Helen F Matthews, Timothy J Jancel, Jack J Bleesing, Rebecca A Marsh, Taco W Kuijpers, Kim E Nichols, Carrie L Lucas, Sunil Nagpal, Huseyin Mehmet, Helen C Su, Jeffrey I Cohen, Gulbu Uzel, Michael J Lenardo.
Abstract
The magnesium transporter 1 (MAGT1) is a critical regulator of basal intracellular free magnesium (Mg(2+)) concentrations. Individuals with genetic deficiencies in MAGT1 have high levels of Epstein-Barr virus (EBV) and a predisposition to lymphoma. We show that decreased intracellular free Mg(2+) causes defective expression of the natural killer activating receptor NKG2D in natural killer (NK) and CD8(+) T cells and impairs cytolytic responses against EBV. Notably, magnesium supplementation in MAGT1-deficient patients restores intracellular free Mg(2+) and NKG2D while concurrently reducing EBV-infected cells in vivo, demonstrating a link between NKG2D cytolytic activity and EBV antiviral immunity in humans. Moreover, these findings reveal a specific molecular function of free basal intracellular Mg(2+) in eukaryotic cells.Entities:
Mesh：
Substances：
Year: 2013 PMID： 23846901 PMCID： PMC3894782 DOI： 10.1126/science.1240094
Source DB: PubMed Journal: Science ISSN： 0036-8075 Impact factor: 47.728